December 11, 2003 (download PDF)
Cypress Bioscience, Inc. Announces Milnacipran Clinical Study Results Demonstrating that Effective Treatment of Fibromylagia-Related Pain is Distinct from the Treatment of Mood

November 12, 2003 (download PDF)
Cypress Bioscience, Inc. Announces Third Quarter 2003 Results

October 28, 2003 (download PDF)
Cypress Bioscience Presents Data at the American College of Rheumatology Annual Meeting Demonstrating Benefits of Milnacipran for Fibromyalgia Patients Using Several Measurements of Pain

October 23, 2003 (download PDF)
Cypress Bioscience, Inc. Broadens its Intellectual Property Position with Receipt of New U.S. Patent for the Use of Milnacipran in the Treatment of Chronic Fatigue Syndrome and Pain

October 21, 2003 (download PDF)
Cypress Bioscience, Inc. Announces Launch of Phase III Milnacipran Program With Fibromyalgia Patients

October 1, 2003 (download PDF)
Cypress Bioscience, Inc. Calls for Redemption Outstanding Warrants Issued in Connection with March 2002 Private Placement

August 14, 2003 (download PDF)
Cypress Bioscience, Inc. Announces Second Quarter 2003 Results

August 5, 2003 (download PDF)
Cypress Bioscience, Inc. Expands Intellectual Property Portfolio with Receipt of New U.S. Patent for the Use of Milnacipran in the Treatment of Fibromyalgia Syndrome

June 25, 2003 (download PDF)
Cypress Bioscience, Inc. Holds Kick-Off Meeting for New Clinical Study Using Milnacipran to Treat Irritable Bowel Syndrome

June 19, 2003 (download PDF)
Cypress Bioscience’s Study Design Used as a Model for Pain Assessment in Clinical Trials

June 9, 2003 (download PDF)
Cypress Bioscience, Inc. Revises Milnacipran License with Pierre Fabre Médicament to Improve Economic Terms and Expand the Licensed Field

May 29, 2003 (download PDF)
Cypress Bioscience, Inc. Drug Milnacipran May Act through Multiple Mechanisms New Data Suggests Distinct Effects on Pain and Mood

May 16, 2003 (download PDF)
Cypress Bioscience, Inc. Drug Milnacipran Demonstrates Efficacy in Cognitive Performance Animal Model

May 15, 2003 (download PDF)
Cypress Bioscience, Inc. Announces First Quarter 2003 Results

May 13, 2003 (download PDF)
Cypress Bioscience Drug Candidate, Milnacipran, Highlighted in Newsweek Magazine ARticle on Fibromyalgia Syndrome

April 7, 2003 (download PDF)
Cypress Bioscience, Inc. Closes $10.3 Million Financing Funds Will be Used to Advance the Company’s FMS and Related Initiatives

March 27, 2003 (download PDF)
Cypress Bioscience, Inc. Enters Into Agreements for Private Placement of Approximately $10.3 Million

March 24, 2003 (download PDF)
Cypress Bioscience, Inc. Announces Results Demonstrating the Superiority of Electronic Diary as a Method to Record Pain Assessments

March 21, 2003 (download PDF)
Cypress Bioscience, Inc. Announces Final Results of Milnacipran Phase II Clinical Trial in Fibromyalgia

March 20, 2003 (download PDF)
Cypress Bioscience, Inc. Announces Fourth Quarter and Fiscal Year End 2002 Results

February 10, 2003 (download PDF)
Cypress Bioscience, Inc. Announces Topline Final Results of Milnacipran Phase II Study in Fibromyalgia Syndrome